Kevin M Koo (Matt Trau)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 23

Top Topics

Radical Prostatectomy

Circulating Tumor

Gold Nanoparticles

Top Venues

Analytical chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Binny Jaradi, Tulika Das, Kevin M Koo
Design and Analytical Evaluation of a Rapid Plasma Screening Assay for Circulating Human Papillomavirus DNA via Thermostable Enzyme Chemistries. Analytical chemistry (2023)
Shuvashis Dey, Kevin M Koo, Emtiaz Ahmed, Matt Trau
Nanophotonic immunoarray with electrochemically roughened surfaces for handheld detection of secreted PD-L1 to predict immuno-oncology efficacy. Lab on a chip (2023)
Tira Jing Ying Tan, J Lynn Fink, Timothy Kwang Yong Tay, Binny Jaradi, Nathan Stone, Paul M Waring, Kevin M Koo, Puay Hoon Tan, Daniel Shao-Weng Tan, Rebecca A Dent
Exquisitely Platinum-Sensitive Triple-Negative Breast Cancer, Time for <i>BRCA</i> Methylation Testing? JCO precision oncology 6 (2022)
Ravi Velaga, Kevin M Koo, Paul N Mainwaring
Harnessing gene fusion-derived neoantigens for 'cold' breast and prostate tumor immunotherapy. Immunotherapy 14 (14) (2022)
Kevin M Koo, Matt Trau
Molecular locker probe enrichment of gene fusion variants from matched patient liquid biopsy specimens for magneto-bioelectrocatalytic nanosensing. Nanoscale 14 (11) (2022)
Jing Wang, Kevin M Koo, Matt Trau
Tetraplex Immunophenotyping of Cell Surface Proteomes via Synthesized Plasmonic Nanotags and Portable Raman Spectroscopy. Analytical chemistry 94 (43) (2022)
Emtiaz Ahmed, Mostafa Kamal Masud, Md Shahriar A Hossain, Jongbeom Na, Abu Ali Ibn Sina, Yamauchi Yusuke, Kevin M Koo
Nanostructured mesoporous gold electrodes detect protein phosphorylation in cancer with electrochemical signal amplification. The Analyst 145 (20) (2021)
Kira J Fitzpatrick, Hayden J Rohlf, Tara D Sutherland, Kevin M Koo, Sam Beckett, Walter O Okelo, Anthony L Keyburn, Branwen S Morgan, Barbara Drigo, Matt Trau, Erica Donner, Steven P Djordjevic, Paul J De Barro
Progressing Antimicrobial Resistance Sensing Technologies across Human, Animal, and Environmental Health Domains. ACS sensors (2021)
Karishma Singh, Ruchika Nalabotala, Kevin M Koo, Sudeep Bose, Ranu Nayak, Mohammad J A Shiddiky
Separation of distinct exosome subpopulations: isolation and characterization approaches and their associated challenges. The Analyst 146 (12) (2021)
Shuvashis Dey, Matt Trau, Kevin M Koo
Surface-Enhanced Raman Spectroscopy for Cancer Immunotherapy Applications: Opportunities, Challenges, and Current Progress in Nanomaterial Strategies. Nanomaterials (Basel, Switzerland) 10 (6) (2020)
Yi Zeng, Kevin M Koo, Ai-Guo Shen, Ji-Ming Hu, Matt Trau
Nucleic Acid Hybridization-Based Noise Suppression for Ultraselective Multiplexed Amplification of Mutant Variants. Small (Weinheim an der Bergstrasse, Germany) 17 (2) (2020)
Kevin M Koo, Matt Trau
Direct Enhanced Detection of Multiple Circulating Tumor DNA Variants in Unprocessed Plasma by Magnetic-Assisted Bioelectrocatalytic Cycling. ACS sensors 5 (10) (2020)
Aswin Raj Kumar, Karthik Balaji Shanmugasundaram, Junrong Li, Zhen Zhang, Abu Ali Ibn Sina, Alain Wuethrich, Kevin M Koo
Ultrasensitive melanoma biomarker detection using a microchip SERS immunoassay with anisotropic Au-Ag alloy nanoboxes. RSC advances 10 (48) (2020)
Kevin M Koo, Paul N Mainwaring, Scott A Tomlins, Matt Trau
Merging new-age biomarkers and nanodiagnostics for precision prostate cancer management. Nature reviews. Urology 16 (5) (2020)
Lyndon J Raftery, Christopher B Howard, Yadveer S Grewal, Ramanathan Vaidyanathan, Martina L Jones, Will Anderson, Darren J Korbie, Tania Duarte, Minh Duc Cao, Son Hoang Nguyen, Lachlan J M Coin, Stephen M Mahler, Kevin M Koo
Retooling phage display with electrohydrodynamic nanomixing and nanopore sequencing. Lab on a chip 19 (24) (2019)
Alain Wuethrich, Abu Ali Ibn Sina, Mostak Ahmed, Ting-Yun Lin, Laura G Carrascosa, Kevin M Koo
Interfacial nano-mixing in a miniaturised platform enables signal enhancement and in situ detection of cancer biomarkers. Nanoscale 10 (23) (2019)
Jing Wang, Kevin M Koo, Yuling Wang, Matt Trau
Engineering State-of-the-Art Plasmonic Nanomaterials for SERS-Based Clinical Liquid Biopsy Applications. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 6 (23) (2019)
Kevin M Koo, Jing Wang, Renée S Richards, Aine Farrell, John W Yaxley, Hema Samaratunga, Patrick E Teloken, Matthew J Roberts, Geoffrey D Coughlin, Martin F Lavin, Paul N Mainwaring, Yuling Wang, Robert A Gardiner, Matt Trau
Design and Clinical Verification of Surface-Enhanced Raman Spectroscopy Diagnostic Technology for Individual Cancer Risk Prediction. ACS nano 12 (8) (2018)
Kevin M Koo, Shuvashis Dey, Matt Trau
Amplification-Free Multi-RNA-Type Profiling for Cancer Risk Stratification via Alternating Current Electrohydrodynamic Nanomixing. Small (Weinheim an der Bergstrasse, Germany) 14 (17) (2018)
Jing Wang, Kevin M Koo, Yuling Wang, Matt Trau
"Mix-to-Go" Silver Colloidal Strategy for Prostate Cancer Molecular Profiling and Risk Prediction. Analytical chemistry 90 (21) (2018)
Jing Wang, Kevin M Koo, Eugene J H Wee, Yuling Wang, Matt Trau
A nanoplasmonic label-free surface-enhanced Raman scattering strategy for non-invasive cancer genetic subtyping in patient samples. Nanoscale 9 (10) (2018)
Kevin M Koo, Shuvashis Dey, Matt Trau
A Sample-to-Targeted Gene Analysis Biochip for Nanofluidic Manipulation of Solid-Phase Circulating Tumor Nucleic Acid Amplification in Liquid Biopsies. ACS sensors 3 (12) (2018)
Abu Ali Ibn Sina, Matthew Thomas Foster, Darren Korbie, Laura G Carrascosa, Mohammad J A Shiddiky, Jing Gao, Shuvashis Dey, Kevin M Koo
A multiplex microplatform for the detection of multiple DNA methylation events using gold-DNA affinity. The Analyst 142 (19) (2017)